Sign In
Buy MEDP
$450.82
+5.23 (+1.17%)
At Close: Jun 03, 2026
These eight health-care stocks can keep you invested in the market with less worry
10:52am, Tuesday, 02'nd Aug 2022
You're tempted to increase exposure to stocks because of the market's strength. But you're still gun shy because of the painful selloff.
Want $1 Million in Retirement? Invest $150,000 in These 3 Stocks and Wait a Decade
10:45am, Tuesday, 02'nd Aug 2022 The Motley Fool
These healthcare stocks could help you retire early, offering impressive margins and promising growth potential.
Teleflex's (TFX) Q2 Earnings Top Estimates, 2022 View Down
01:47pm, Monday, 01'st Aug 2022 Zacks Investment Research
For UroLift, Teleflex (TFX) witnesses revenue declines in all sites of service, including hospital, ASC and physician's office.
Chemed (CHE) Q2 Earnings Surpass Estimates, Margins Grow
05:57pm, Friday, 29'th Jul 2022 Zacks Investment Research
Chemed (CHE) reports better-than-expected earnings in the second quarter, with a robust performance by the Roto-Rooter segment driving the top line.
Edwards Lifesciences (EW) Q2 Earnings Meet Estimates, Margins Up
05:54pm, Friday, 29'th Jul 2022 Zacks Investment Research
Edwards Lifesciences (EW) posts Q2 earnings in line with the Zacks Consensus Estimate, with robust performances across all product groups driving the top line.
Amedisys (AMED) Q2 Earnings Surpass Estimates, Margins Down
03:57pm, Friday, 29'th Jul 2022 Zacks Investment Research
Lower utilization of home health benefit, primarily driven by lesser total discharges to post-acute settings, hampers Amedisys' (AMED) Q2 revenues.
Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Gross Margin Up
03:28pm, Friday, 29'th Jul 2022 Zacks Investment Research
Overall demand for Bio-Rad's (BIO) Life Science and Clinical Diagnostics continues to be strong on localized surges of COVID-19.
LabCorp (LH) Q2 Earnings Top Estimates, Raises '22 EPS View
05:15pm, Thursday, 28'th Jul 2022 Zacks Investment Research
LabCorp (LH) posts better-than-expected earnings in the second quarter and demonstrates continued strength in the organic Base Business.
Hologic (HOLX) Q3 Earnings Beat Estimates, Margins Down
05:14pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Hologic (HOLX) reports better-than-expected results in the fiscal third quarter with robust sales performance in the GYN Surgical business.
QIAGEN (QGEN) Q2 Earnings Top Estimates, Margins Decline
04:50pm, Thursday, 28'th Jul 2022 Zacks Investment Research
QIAGEN (QGEN) posts better-than-expected results for the second quarter and raises its sales and earnings outlook for 2022 amid the uncertain macroeconomic environment.
Thermo Fisher (TMO) Q2 Earnings Top Estimates, Margins Down
02:44pm, Thursday, 28'th Jul 2022 Zacks Investment Research
The year-over-year decline in Thermo Fisher's (TMO) Life Science Solutions and Specialty Diagnostics segment revenues is disappointing.
West Pharmaceutical (WST) Q2 Earnings Beat, FY22 View Cut
01:53pm, Thursday, 28'th Jul 2022 Zacks Investment Research
West Pharmaceutical's (WST) second-quarter earnings reflect strength in the Proprietary Products segment.
Merit Medical (MMSI) Q2 Earnings Beat, FY22 View Revised
01:51pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Merit Medical (MMSI), in the second quarter, benefits from revenue growth in both its segments and from all product categories within its Cardiovascular unit.
Medpace: On Pace After Q1 FY22 Earnings Momentum
12:41pm, Wednesday, 27'th Jul 2022
Medpace delivered a robust set of Q2 earnings with upsides on revenue and operating income. The company printed above-average FCF conversion and continues to deliver on long-term capital management tr
Medpace Holdings, Inc. Common Stock (MEDP) Q2 2022 Earnings Call Transcript
06:30pm, Tuesday, 26'th Jul 2022 The Motley Fool
MEDP earnings call for the period ending June 30, 2022.
